HETEROARYL DERIVATIVES AS PARP INHIBITORS
Disclosed are compounds of formula (I), their tautomeric forms, stereoisomers, and pharmaceutically acceptable salts thereof, wherein ring Ar, ring B, R1-R5, X, Y, p, q, r, and s are as defined in the specification, pharmaceutical compositions including a compound, tautomer, stereoisomer, or salt th...
Saved in:
Main Authors | , , , , , , , |
---|---|
Format | Patent |
Language | English Spanish |
Published |
28.05.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Disclosed are compounds of formula (I), their tautomeric forms, stereoisomers, and pharmaceutically acceptable salts thereof, wherein ring Ar, ring B, R1-R5, X, Y, p, q, r, and s are as defined in the specification, pharmaceutical compositions including a compound, tautomer, stereoisomer, or salt thereof, and methods of treating or preventing diseases or disorders, for example, cancer, that are amenable to treatment or prevention by inhibiting the PARP enzyme of a subject.
Se dan a conocer compuestos de fórmula (I), sus formas tautoméricas, estereoisómeros y sales farmacéuticamente aceptables de los mismos,(ver formula) en la que el anillo Ar, el anillo B, R1-R5, X, Y, p, q, r y s son tal como se definen en la memoria descriptiva, composiciones farmacéuticas que incluyen un compuesto, tautómero, estereoisómero o sal del mismo, y métodos de tratamiento o prevención de enfermedades o trastornos, por ejemplo, cáncer, que son sensibles a tratamiento o prevención mediante inhibición de la enzima PARP de un sujeto. |
---|---|
Bibliography: | Application Number: MX20180001871 |